Purchases and Sales Made in Q4 2021 in Ambrx Biopharma Inc. (AMAM)
This table provides information about the institutional ownership of Ambrx Biopharma Inc. (AMAM) during Q4 2021. The information is specifically focused on institutions that hold shares of Ambrx Biopharma Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 10, 2022
Q4 2021
|
Black Rock Inc.
New York, NY |
BUY
|
- |
2.05M+ 249.84% |
$16.6M - $28.5M
|
2.87M
$80.3M
|
|
|
Feb 11, 2022
Q4 2021
|
Artal Group S.A.
Luxembourg, N4 |
BUY
|
- |
1.3M+ 153.21% |
$10.6M - $18.1M
|
2.15M
$60.3M
|
|
|
Feb 14, 2022
Q4 2021
|
Suvretta Capital Management, LLC
New York, NY |
BUY
|
- |
132K+ 14.22% |
$1.07M - $1.83M
|
1.06M
$29.6M
|
|
|
Feb 14, 2022
Q4 2021
|
Adage Capital Partners Gp, L.L.C.
Boston, MA |
BUY
|
- |
96.4K+ 5.28% |
$782K - $1.34M
|
1.92M
$53.9M
|
|
|
Mar 09, 2022
Q4 2021
|
Norges Bank
Oslo, Q8 |
BUY
|
- |
70KNew |
$568K - $974K
|
70K
$1.96M
|
|
|
Feb 11, 2022
Q4 2021
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
BUY
|
- |
11.8KNew |
$95.7K - $164K
|
11.8K
$330K
|
|
|
Feb 08, 2022
Q4 2021
|
Bank Of America Corp
Charlotte, NC |
BUY
|
- |
30+ 29.7% |
$243 - $417
|
131
$3.67K
|
|
|
Feb 07, 2022
Q4 2021
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Feb 02, 2022
Q4 2021
|
Migdal Insurance & Financial Holdings Ltd.
|
SELL
|
- |
-76- 38.0% |
$616 - $1.06K
|
124
$3.47K
|
|
|
Feb 14, 2022
Q4 2021
|
Octagon Capital Advisors LP
New York, NY |
SELL
|
- |
-13.1K- 3.75% |
$107K - $183K
|
337K
$9.43M
|
|
|
Feb 14, 2022
Q4 2021
|
Ghisallo Capital Management LLC
Greenwich, CT |
SELL
|
- |
-15KClosed |
$122K - $209K
|
0
$0
|
|
|
Feb 14, 2022
Q4 2021
|
Caas Capital Management LP
New York, NY |
SELL
|
- |
-26.9K- 67.33% |
$218K - $375K
|
13.1K
$366K
|